Multiple System Atrophy (MSA) and smoking: a meta-analysis and mechanistic insights

Tseng FS, Deng X, Ong YL, Li HH, Tan EK.

Aging (Albany NY). 2020 Nov 7;12(21):21959-21970. doi: 10.18632/aging.104021. Epub 2020 Nov 7.

Botulinum toxin type A therapy for blepharospasm

Duarte GS, Rodrigues FB, Marques RE, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J.

Cochrane Database Syst Rev. 2020 Nov 19;11:CD004900. doi: 10.1002/14651858.CD004900.pub3.

Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Tristán-Noguero A, Borràs E, Molero-Luis M, Wassenberg T, Peters T, Verbeek MM, Willemsen M, Opladen T, Jeltsch K, Pons R, Thony B, Horvath G, Yapici Z, Friedman J, Hyland K, Agosta GE, López-Laso E,

Mov Disord. 2020 Nov 5. doi: 10.1002/mds.28362. Online ahead of print.

Striatal Dopamine Deficit and Motor Impairment in Idiopathic Normal Pressure Hydrocephalus

Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, Trifirò G, Ceravolo R, Vitali P, Isaias IU, Fasano A, Pacchetti C.

Mov Disord. 2020 Nov 5. doi: 10.1002/mds.28366. Online ahead of print.

PNPT1 mutations may cause Aicardi-Goutières-Syndrome

Bamborschke D, Kreutzer M, Koy A, Koerber F, Lucas N, Huenseler C, Herkenrath P, Lee-Kirsch MA, Cirak S.

Brain Dev. 2020 Nov 3:S0387-7604(20)30283-7. doi: 10.1016/j.braindev.2020.10.005. Online ahead of print.

Essential Tremor - A Cerebellar Driven Disorder?

Fasil Ibrahim M, Beevis JC, Empson RM.

Neuroscience. 2020 Nov 17:S0306-4522(20)30718-1. doi: 10.1016/j.neuroscience.2020.11.002. Online ahead of print.

COVID-19 and stroke: Red flags for secondary movement disorders?

Victorino DB, Guimarães-Marques M, Nejm M, Scorza FA, Scorza CA.

eNeurologicalSci. 2020 Dec;21:100289. doi: 10.1016/j.ensci.2020.100289. Epub 2020 Nov 10.

Clinical and Kinematic Features of Valproate-Induced Tremor and Differences with Essential Tremor

Paparella G, Angelini L, De Biase A, Cannavacciuolo A, Colella D, Di Bonaventura C, Giallonardo AT, Berardelli A, Bologna M.

Cerebellum. 2020 Nov 16. doi: 10.1007/s12311-020-01216-5. Online ahead of print.

Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease

van der Zee S, Müller MLTM, Kanel P, van Laar T, Bohnen NI.

Mov Disord. 2020 Nov 2. doi: 10.1002/mds.28360. Online ahead of print.

Mitochondrial and Clearance Impairment in p.D620N VPS35 Patient-Derived Neurons

Hanss Z, Larsen SB, Antony P, Mencke P, Massart F, Jarazo J, Schwamborn JC, Barbuti PA, Mellick GD, Krüger R.

Mov Disord. 2020 Nov 3. doi: 10.1002/mds.28365. Online ahead of print.

Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration

Klopstock T, Videnovic A, Bischoff AT, Bonnet C, Cif L, Comella C, Correa-Vela M, Escolar ML, Fraser JL, Gonzalez V, Hermanowicz N, Jech R, Jinnah HA, Kmiec T, Lang A, Martí MJ, Mercimek-Andrews S, Mo

Mov Disord. 2020 Nov 16. doi: 10.1002/mds.28392. Online ahead of print.

The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease

García-Sanz P, M F G Aerts J, Moratalla R.

Mov Disord. 2020 Nov 21. doi: 10.1002/mds.28396. Online ahead of print.

Rare variant analysis of essential tremor-associated genes in early-onset Parkinson's disease

Liang D, Zhao Y, Pan H, Zhou X, He R, Zhou X, Yang J, Wang Y, Zhou X, Zhou Z, Xu Q, Yan X, Li J, Guo J, Tang B, Sun Q.

Ann Clin Transl Neurol. 2020 Nov 13. doi: 10.1002/acn3.51248. Online ahead of print.

Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease

Pagan FL, Wilmarth B, Torres-Yaghi Y, Hebron ML, Mulki S, Ferrante D, Matar S, Ahn J, Moussa C.

Mov Disord. 2020 Nov 20. doi: 10.1002/mds.28389. Online ahead of print.

Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha-Synucleinopathies

Stang CD, Mullan AF, Hajeb M, Camerucci E, Turcano P, Martin P, Mielke MM, Josephs KA, Bower JH, St Louis EK, Boeve BF, Savica R.

Ann Neurol. 2020 Nov 6. doi: 10.1002/ana.25952. Online ahead of print.